Our Company

Our Purpose

To turn scientific progress into meaningful possibilities for patients with serious and rare genetic diseases.

At Exir Gene Pharmed, we believe that rarity should never limit the possibility of treatment. Our purpose is to translate advances in genetic medicine into therapies that can make a meaningful difference in patients’ lives.

By combining scientific innovation, responsible development, and a focus on unmet medical needs, we aim to bring the promise of gene therapy closer to the patients and families who need it most.

A clinician speaking with a mother and child in a bright genetic medicine care setting
Scientists collaborating on genetic medicine research in a modern laboratory

Our Vision

A future where advanced genetic medicines are within reach for every patient who needs them.

We envision a world in which transformative therapies are not defined by geography, rarity, or limited access.

Our ambition is to contribute to the next generation of genetic medicine by developing innovative, reliable, and accessible therapies for severe inherited diseases, while building the scientific and technological capabilities needed to bring these treatments from research to patients.

Our Strategy

Focused science. Integrated development. Meaningful impact.

Our strategy is built around a focused approach to genetic medicine, prioritizing diseases with significant unmet medical need where gene-based therapies have the potential to create meaningful clinical impact.

We integrate research, preclinical development, manufacturing, quality, regulatory science, and clinical translation within a connected development pathway. This enables us to move promising ideas efficiently from the laboratory toward clinical application while maintaining a strong focus on quality, safety, and scientific rigor.

As our capabilities grow, we aim to expand our platform across rare and serious genetic diseases and develop a sustainable pipeline of next-generation genetic medicines.

Biopharmaceutical manufacturing scientist inspecting a vial in a controlled production facility
Scroll to Top